drugset

drugset / Trial / NCT01212471

A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease

NCT01212471 ↗

Phase 3 Completed 840 enrolled Bausch & Lomb Incorporated

RandomizedParallel-groupDouble-blindTreatment

Summary

A dose ranging study to evaluate safety and efficacy of bromfenac ophthalmic solution in dry eye disease.

Timeline

Start: 2010-09
Primary completion: 2011-08
Completion: 2011-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bromfenac	Other / unclassified	—	—

Indications